The Technical Analyst
Select Language :
Tricida Inc [TCDA]

Exchange: NASDAQ Sector: Healthcare Industry: Biotechnology

Tricida Inc Price, Forecast, Insider, Ratings, Fundamentals & Signals

Tricida Inc is listed at the  Exchange

0.00% $0.108

America/New_York / 23 jan 2023 @ 16:00


FUNDAMENTALS
MarketCap: 5.95 mill
EPS: -5.29
P/E: -0.0204
Earnings Date: Mar 27, 2023
SharesOutstanding: 55.11 mill
Avg Daily Volume: 12.58 mill
RATING 2023-03-27
B-
Neutral
RATINGS
Rating CashFlow: Strong Buy
Return On Equity: Buy
Return On Asset: Sell
DE: Sell
P/E: Strong Sell
Price To Book: Strong Sell
QUARTER GROWTHS
2/213/214/211/222/223/22
Revenuen/an/an/an/an/an/a
Gr.Profitn/an/an/an/an/an/a
Ebit
Asset
Debt
PE RATIO: COMPANY / SECTOR
0.00x
Company: PE -0.0204 | sector: PE -3.05
PE RATIO: COMPANY / INDUSTRY
0.00x
Company: PE -0.0204 | industry: PE 5.88
DISCOUNTED CASH FLOW VALUE
N/A
N/A
Expected Trading Range (DAY)

$ 0.0260 - 0.190

( +/- 75.93%)
ATR Model: 14 days

Insider Trading

Date Person Action Amount type
2022-11-22 Orbimed Advisors Llc Sell 1 034 421 Common Stock
2022-11-23 Orbimed Advisors Llc Sell 5 617 300 Common Stock
2022-11-25 Orbimed Advisors Llc Sell 3 629 226 Common Stock
2022-11-22 Bonita David P Sell 1 034 421 Common Stock
2022-11-23 Bonita David P Sell 5 617 300 Common Stock
INSIDER POWER
-75.78
Last 100 transactions
Buy: 5 461 904 | Sell: 28 520 680

Forecast: 01:40 - $-3.29

Live Trading Signals (every 1 min)

SCORE
10.00
Buy
Score Algorithm Version: 1.2C
Last version updated: Fri April 15th, 2022
Indicator Signals
RSI 21
SMA
Trend
Trend 2
Trend 3
MACD
Volume Signals
Price $0.108 (0.00% )
Volume 31.13 mill
Avg. Vol. 12.58 mill
% of Avg. Vol 247.50 %
Signal 1:
Signal 2:

Today

Intraday chart data with high, low, open and close for Tricida Inc

Last 12 Months

Last 12 months chart data with high, low, open and close for Tricida Inc

RSI

Intraday RSI14 chart for Tricida Inc

Last 10 Buy & Sell Signals For TCDA

0 Signals | Accuracy: 0.00% | Accuracy Buy: 0.00% | Accuracy Sell: 0.00%

Avg return buy: 0.00 % | Avg return sell: 0.00 %

$1 invested is now $1.00 or 0.00% since Coming Soon

Date Signal @ Closed %
Profile picture for
            Tricida Inc

TCDA

Tricida, Inc. operates as a pharmaceutical company. It focuses on the development and commercialization of veverimer (TRC101), a non-absorbed orally-administered polymer that has completed Phase III trial to treat metabolic acidosis in patients with chronic kidney disease by binding and removing acid from the gastrointestinal track. The company was incorporated in 2013 and is headquartered in South San Francisco, California.

Last 10 Buy Signals

Date Signal @
GALAUSDMar 29 - 05:34$0.0647
AVAXUSDMar 29 - 05:33$53.44
CGOUSDMar 29 - 05:2971.87
CVCUSDMar 29 - 05:31$0.206
RIOUSDMar 29 - 05:292.43
TAOUSDMar 29 - 05:29531.83
PROPCUSDMar 29 - 05:254.70
DUSKUSDMar 29 - 05:230.575
ETHUPUSDMar 29 - 05:2134.38
EGXUSDMar 29 - 05:20200.18

Latest Press Releases

Latest News

Disclaimer:

"JimStromberg.com" is a research service that provides financial data and technical analysis of publicly traded stocks. All users should speak with their financial advisor before buying or selling any securities. Users should not base their investment decision upon "JimStromberg.com". By using the site you agree and are held liable for your own investment decisions and agree to Terms of Use and Privacy Policy. Please read the full disclaimer here.